Wealth Enhancement Advisory Services LLC Has $6.97 Million Stock Holdings in STERIS plc $STE

Wealth Enhancement Advisory Services LLC lifted its stake in shares of STERIS plc (NYSE:STE) by 23.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,763 shares of the medical equipment provider’s stock after acquiring an additional 5,095 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in STERIS were worth $6,971,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in STE. Steigerwald Gordon & Koch Inc. acquired a new stake in STERIS during the 3rd quarter valued at approximately $25,000. Board of the Pension Protection Fund acquired a new position in shares of STERIS in the 4th quarter worth approximately $25,000. Harbor Investment Advisory LLC lifted its position in shares of STERIS by 115.4% in the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 60 shares during the period. Cloud Capital Management LLC bought a new stake in shares of STERIS in the 3rd quarter valued at $29,000. Finally, Geneos Wealth Management Inc. increased its position in shares of STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 104 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research report on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, STERIS currently has a consensus rating of “Moderate Buy” and an average price target of $275.20.

STERIS Price Performance

Shares of NYSE STE opened at $219.90 on Friday. The firm has a market capitalization of $21.57 billion, a P/E ratio of 30.67 and a beta of 1.05. The firm’s 50-day moving average price is $242.75 and its 200-day moving average price is $248.76. The company has a current ratio of 2.48, a quick ratio of 1.75 and a debt-to-equity ratio of 0.26. STERIS plc has a 1-year low of $204.90 and a 1-year high of $269.44.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 EPS for the quarter, meeting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.During the same period in the prior year, the firm posted $2.32 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th were issued a dividend of $0.63 per share. The ex-dividend date was Tuesday, February 17th. This represents a $2.52 annualized dividend and a dividend yield of 1.1%. STERIS’s payout ratio is currently 35.15%.

Insider Activity at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the company’s stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $237.21, for a total transaction of $734,876.58. Following the transaction, the director directly owned 705 shares of the company’s stock, valued at $167,233.05. This represents a 81.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.07% of the stock is currently owned by corporate insiders.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.